Literature DB >> 12387356

Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate.

Keith M Erikson1, Robert L Suber, Michael Aschner.   

Abstract

Manganese (Mn)-induced neurotoxicity can occur due to environmental exposure (air pollution, soil, water) and/or metabolic aberrations (decreased biliary excretion). High brain manganese levels lead to oxidative stress, as well as alterations in neurotransmitter metabolism with concurrent neurobehavioral deficits. Based on the few existing studies that have examined brain regional Mn concentration, it is likely that in pathological conditions, Mn concentration can reach between 100 and 500 microM. Environmental Mn exposure as a result of methylcyclopentadienyl manganese tricarbonyl (MMT) combustion is in the form of phosphate or sulfate (MnPO4, MnSO4, respectively). Pharmacokinetic studies have shown that the Mn salt will determine the rate of transport into the brain: MnCl2 > MnSO4 > MnPO4. The salt-specific neurotoxicity of these species is unknown. The primary goal of this study was to examine gene expression of glutamate/aspartate transporter (GLAST), taurine transporter (tau-T), and metallothionein-I (MT-I) in astrocytes exposed to manganese chloride (MnCl2), manganese sulfate (MnSO4), and manganese phosphate (MnPO4). We hypothesized that the effects of MnPO4 and MnSO4 exposure on GLASTexpression in astrocytes would be similar to those induced by MnCl2, since irrespective of salt species exposure, once internalized by astrocytes, the Mn ion would be identically complexed. At the same time, we hypothesized that the magnitude of the effect would be salt-dependent, since the chemical speciation would determine the rate of intracellular uptake of Mn. MnCl2 caused a significant overall decrease (P < 0.0001) in astrocytic GLAST mRNA levels with MnSO4 causing a moderate decrease. MnPO4 exposure did not alter GLAST mRNA in astrocytes. We also sought to examine astrocytic metallothionein and taurine transporter gene expression as markers of manganese exposure. Our findings suggest that manganese chloride significantly decreased (P < 0.0001) astrocytic metallothionein mRNA compared to both the sulfate and phosphate species. However, astrocytic taurine transporter mRNA was not affected by Mn exposure, irrespective of the salt species. These data are consistent with the hypothesis that astrocytic neurotoxicity due to Mn exposure is dependent upon its species, with solubility, and by inference, intracellular concentration, representing a major determinant of its neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387356     DOI: 10.1016/s0161-813x(02)00041-4

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  13 in total

1.  Fluoxetine and Riluzole Mitigates Manganese-Induced Disruption of Glutamate Transporters and Excitotoxicity via Ephrin-A3/GLAST-GLT-1/Glu Signaling Pathway in Striatum of Mice.

Authors:  Zhipeng Qi; Xinxin Yang; Yanqi Sang; Yanan Liu; Jiashuo Li; Bin Xu; Wei Liu; Miao He; Zhaofa Xu; Yu Deng; Jinghai Zhu
Journal:  Neurotox Res       Date:  2020-05-29       Impact factor: 3.911

Review 2.  Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Lee
Journal:  Neurochem Int       Date:  2014-08-13       Impact factor: 3.921

3.  Mechanism of Mn(II)-mediated dysregulation of glutamine-glutamate cycle: focus on glutamate turnover.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Michael Aschner
Journal:  J Neurochem       Date:  2012-07-09       Impact factor: 5.372

Review 4.  Manganese exposure and induced oxidative stress in the rat brain.

Authors:  Keith M Erikson; Allison W Dobson; David C Dorman; Michael Aschner
Journal:  Sci Total Environ       Date:  2004-12-01       Impact factor: 7.963

5.  Low-level manganese exposure alters glutamate metabolism in GABAergic AF5 cells.

Authors:  Daniel R Crooks; Nicholas Welch; Donald R Smith
Journal:  Neurotoxicology       Date:  2007-01-16       Impact factor: 4.294

Review 6.  Manganese neurotoxicity: a focus on the neonate.

Authors:  Keith M Erikson; Khristy Thompson; Judy Aschner; Michael Aschner
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310

7.  Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes.

Authors:  Eun-Sook Y Lee; Marta Sidoryk; Haiyan Jiang; Zhaobao Yin; Michael Aschner
Journal:  J Neurochem       Date:  2009-04-22       Impact factor: 5.372

8.  In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function.

Authors:  Fabiano M Cordova; Aderbal S Aguiar; Tanara V Peres; Mark W Lopes; Filipe M Gonçalves; Aline P Remor; Samantha C Lopes; Célso Pilati; Alexandra S Latini; Rui D S Prediger; Keith M Erikson; Michael Aschner; Rodrigo B Leal
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

Review 9.  "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".

Authors:  Tanara V Peres; Maria Rosa C Schettinger; Pan Chen; Fabiano Carvalho; Daiana S Avila; Aaron B Bowman; Michael Aschner
Journal:  BMC Pharmacol Toxicol       Date:  2016-11-04       Impact factor: 2.483

10.  Modulation of Glutamate Transporter EAAT1 and Inward-Rectifier Potassium Channel Kir4.1 Expression in Cultured Spinal Cord Astrocytes by Platinum-Based Chemotherapeutics.

Authors:  Markus Leo; Linda-Isabell Schmitt; Rebecca Steffen; Andrea Kutritz; Christoph Kleinschnitz; Tim Hagenacker
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.